Partner & CEO

jim.hawkins@whitefalconadvisors.com

240-354-7300

Dr. Hawkins, a bio sciences expert, raised equity and debt capital for many biotechnology companies including Synthecell Corporation and NeuroTrophic Bioscience Inc., a drug discovery company.

He was instrumental in the acquisition of Vega Biotechnologies, Inc. and the sale of Genetic MediSyn Corp, an antisense technology company.

Dr. Hawkins also served as CEO of Synthecell, Bio-Tech Imaging, Inc., a cell-based diagnostics company; SensorChem Corp., a scientific instrument company, Genetic MediSyn, and NeuroTrophic Bioscience Inc.

Dr. Hawkins was also a Managing Director in Focus Investment Bankers where he developed Team strategy and helped direct transaction implementation.

Dr. Hawkins co-founded and was former Editor-in-Chief of the peer-reviewed scientific journal Antisense Research and Development. He received his doctorate in molecular biology from Baylor College of Medicine in Houston, Texas.

He conducted post-doctoral studies at the National Institutes of Health in Bethesda, Maryland, and served as a Full Professor and Director of the Biotechnology Program at Georgetown University.

Dr. Hawkins also holds an MBA degree from George Mason University in Fairfax, Virginia.